CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key Findings
3.2.1 Top impacting factor
3.2.2 Top winning strategies
3.3.3 Top investment pockets
3.3 Porters five forces analysis
3.3.1 Low bargaining power of suppliers due to large number of suppliers and low switching cost
3.3.2 Moderate bargaining power of buyer due to large number of buyer, high product dependency and less switching cost.
3.3.3 Low threat of substitutes due to low preference of substitutes and high brand loyalty
3.3.4 Low threat of new entrants due to presence of dominant players and strict government regulations
3.3.5 Presence of numerous players, high exist barriers, high economic base increases the competition among rivalries
3.4 Market share analysis, 2015
3.5 Drivers
3.5.1 Rapidly changing lifestyle patterns such as increasing consumption of alcohol, and unhealthy diets
3.5.2 Increasing prevalence of liver diseases
3.5.3 Growing geriatric population
3.5.4 Increasing government and non-government awareness programs
3.5.5 Increasing R&D investments for the development of novel therapies
3.6 Restraint
3.6.1 Stringent government regulations
3.6.2 High cost incurred in drug R&D
3.6.3 Side effect associated with medication
3.7 Opportunities
3.7.1 Availability of generic and bio-similar drugs
CHAPTER 4 WORLD LIVER DISEASE TREATMENT MARKET, BY TREATMENT TYPE
4.1 Introduction
4.2 Anti Viral Drugs
4.2.1 KEY MARKET TRENDS
4.2.2 KEY GROWTH FACTORS AND OPPORTUNITIES
4.2.3 MARKET SIZE AND FORECAST
4.2.4 NORTH AMERICA ANTIVIRAL DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
4.2.5 EUROPE ANTIVIRAL DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
4.2.6 ASIA PACIFIC ANTIVIRAL DRUGS MARKET, ($MILLION), GROWTH (%) 2014-202
4.2.7 LAMEA ANTIVIRAL DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
4.3 Vaccines
4.3.1 KEY MARKET TRENDS
4.3.2 KEY GROWTH FACTORS AND OPPORTUNITIES
4.3.3 MARKET SIZE AND FORECAST
4.3.4 NORTH AMERICA VACCINES MARKET, ($MILLION), GROWTH (%) 2014-2022
4.3.5 EUROPE VACCINES MARKET, ($MILLION), GROWTH (%) 2014-2022
4.3.6 ASIA PACIFIC VACCINES MARKET, ($MILLION), GROWTH (%) 2014-2022
4.3.7 LAMEA VACCINES MARKET, ($MILLION), GROWTH (%) 2014-2022
4.4 Anti Rejection Drugs/ Immunosuppressant Drugs
4.4.1 KEY MARKET TRENDS
4.4.2 KEY GROWTH FACTORS AND OPPORTUNITIES
4.4.3 MARKET SIZE AND FORECAST
4.4.4 NORTH AMERICA ANTI REJECTION DRUGS / IMMUNOSUPPRESANT DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
4.4.5 EUROPE ANTI REJECTION DRUGS / IMMUNOSUPPRESANT DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
4.4.6 ASIA PACIFIC ANTI REJECTION DRUGS / IMMUNOSUPPRESANT DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
4.4.7 LAMEA ANTI REJECTION DRUGS / IMMUNOSUPPRESANT DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
4.5 Chemotherapy Drugs
4.5.1 KEY MARKET TRENDS
4.5.2 KEY GROWTH FACTORS AND OPPORTUNITIES
4.5.3 MARKET SIZE AND FORECAST
4.5.4 NORTH AMERICA CHEMOTHERAPY DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
4.5.5 EUROPE CHEMOTHERAPY DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
4.5.6 ASIA PACIFIC CHEMOTHERAPY DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
4.5.7 LAMEA CHEMOTHERAPY DRUGS MARKET, ($MILLION), GROWTH (%) 2014-2022
4.6 Targeted Therapy
4.6.1 KEY MARKET TRENDS
4.6.2 KEY GROWTH FACTORS AND OPPORTUNITIES
4.6.3 MARKET SIZE AND FORECAST
4.6.4 NORTH AMERICA TARGETED THERAPY MARKET, ($MILLION), GROWTH (%) 2014-2022
4.6.5 EUROPE TARGETED THERAPY MARKET, ($MILLION), GROWTH (%) 2014-2022
4.6.6 ASIA PACIFIC TARGETED THERAPY MARKET, ($MILLION), GROWTH (%) 2014-2022
4.6.7 LAMEA TARGETED THERAPY MARKET, ($MILLION), GROWTH (%) 2014-2022
4.7 Immunoglobulin
4.7.1 KEY MARKET TRENDS
4.7.2 KEY GROWTH FACTORS AND OPPORTUNITIES
4.7.3 MARKET SIZE AND FORECAST
4.7.4 NORTH AMERICA IMMUNOGLOBULIN MARKET, ($MILLION), GROWTH (%) 2014-2022
4.7.5 EUROPE IMMUNOGLOBULIN MARKET, ($MILLION), GROWTH (%) 2014-2022
4.7.6 ASIA PACIFIC IMMUNOGLOBULIN MARKET, ($MILLION), GROWTH (%) 2014-2022
4.7.7 LAMEA IMMUNOGLOBULIN MARKET, ($MILLION), GROWTH (%) 2014-2022
4.8 Corticosteroids
4.8.1 KEY MARKET TRENDS
4.8.2 KEY GROWTH FACTORS AND OPPORTUNITIES
4.8.3 MARKET SIZE AND FORECAST
4.8.4 NORTH AMERICA CORTICOSTEROIDS MARKET, ($MILLION), GROWTH (%) 2014-2022
4.8.5 EUROPE CORTICOSTEROIDS MARKET, ($MILLION), GROWTH (%) 2014-2022
4.8.6 ASIA PACIFIC CORTICOSTEROIDS MARKET, ($MILLION), GROWTH (%) 2014-2022
4.8.7 LAMEA CORTICOSTEROIDS MARKET, ($MILLION), GROWTH (%) 2014-2022
CHAPTER 5 WORLD LIVER DISEASE TREATMENT MARKET, BY GEOGRAPHY
5.1 Introduction
5.2 North America
5.2.1 KEY MARKET TRENDS
5.2.2 KEY GROWTH FACTORS AND OPPORTUNITIES
5.2.3 MARKET SIZE AND FORECAST
5.2.4 U.S. LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
5.2.5 MEXICO LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
5.2.6 CANADA LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
5.3 Europe
5.3.1 KEY MARKET TRENDS
5.3.2 KEY GROWTH FACTORS AND OPPORTUNITIES
5.3.3 MARKET SIZE AND FORECAST
5.3.4 GERMANY LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
5.3.5 UK LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
5.3.6 ITALY LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
5.3.7 FRANCE LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
5.3.8 REST OF EUROPE LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
5.4 Asia Pacific (APAC)
5.4.1 KEY MARKET TRENDS
5.4.2 KEY GROWTH FACTORS AND OPPORTUNITIES
5.4.3 MARKET SIZE AND FORECAST
5.4.4 JAPAN LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
5.4.5 CHINA LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
5.4.6 INDIA LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
5.4.7 REST OF APAC LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
5.5 LAMEA
5.5.1 KEY MARKET TRENDS
5.5.2 KEY GROWTH FACTORS AND OPPORTUNITIES
5.5.3 MARKET SIZE AND FORECAST
5.5.4 LATIN AMERIC LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
5.5.5 MIDDLE EAST LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
5.5.6 AFRICA LIVER DISEASE TREATMENT MARKET, ($MILLION), GROWTH (%) 2014-2022
